Paper273269
Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
McNally NJ and 4 others. Radiat Res, 1978. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer. Papers, record 273269. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/273269
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms, Experimental | Major topic |
| Nitroimidazoles | Major topic |
| Radiation-Sensitizing Agents | Major topic |
| Animals | |
| Female | |
| Fibrosarcoma | |
| Male | |
| Mammary Neoplasms, Experimental | |
| Mice | |
| Neoplasm Transplantation | |
| Osteosarcoma | |
| Oxygen | |
| Time Factors | |
| Transplantation, Isogeneic |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7460192 | Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in mice. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7460192 | PubMed |
| 7427595 | Radiosensitisers. | Br Med J | 1980 | https://conductscience.org/library/papers/7427595 | PubMed |
| 7370170 | Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7370170 | PubMed |
| 7362770 | Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7362770 | PubMed |
| 7362769 | Is tumour radiosensitization by misonidazole a general phenomenon? | Br J Cancer | 1980 | https://conductscience.org/library/papers/7362769 | PubMed |
| 7295516 | Phenytoin-induced changes in the pharmacokinetics of misonidazole in radiotherapy patients. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7295516 | PubMed |
| 7248157 | Enhancement of the effect of cytotoxic drugs by radiosensitizers. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7248157 | PubMed |
| 7104192 | In vivo assessment of basic 2-nitroimidazole radiosensitizers. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7104192 | PubMed |
| 7059476 | The penetration of misonidazole into a mature structural cartilage. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7059476 | PubMed |
| 6932914 | In vivo-in vitro tumour cell lines: characteristics and limitations as models for human cancer. | Br J Cancer Suppl | 1980 | https://conductscience.org/library/papers/6932914 | PubMed |
| 6547051 | Radiation sensitization and chemopotentiation: RSU 1069, a compound more efficient than misonidazole in vitro and in vivo. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6547051 | PubMed |
| 6519157 | The pharmacokinetics of a new radiosensitiser, Ro 03-8799 in humans. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6519157 | PubMed |
| 3719893 | Distribution and tumor penetration properties of a radiosensitizer 2-[14C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3719893 | PubMed |
| 2110814 | Bioreductive drugs and the selective induction of tumour hypoxia. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2110814 | PubMed |
| 508562 | Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. | Br J Cancer | 1979 | https://conductscience.org/library/papers/508562 | PubMed |
| 486305 | Distribution of misonidazole in human tumours and normal tissues. | Br J Cancer | 1979 | https://conductscience.org/library/papers/486305 | PubMed |
| 465300 | Pharmacokinetic considerations in testing hypoxic cell radiosensitizers in mouse tumours. | Br J Cancer | 1979 | https://conductscience.org/library/papers/465300 | PubMed |
| 289406 | The penetration of misonidazole into spontaneous canine tumours. | Br J Cancer | 1979 | https://conductscience.org/library/papers/289406 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/273269
GET https://conductscience.org/api/papers/v1/273269/authors